Breeze Meds vs Maximus: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Breeze Meds scores higher on our rubric, 7.3/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Maximus - published $79.99/mo; total not verified →or find your match

Breeze Meds beats Maximus overall, scoring 7.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Maximus is published $79.99/mo; total not verified. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols.

A side-by-side look at Breeze Meds and Maximus to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Breeze Meds

#29 of 54

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Maximus

#50 of 54

5.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Feature	Breeze Meds	Maximus
Why each one	No subscription required, pay per order rather than committing to recurring billing, with three formulation options including oral tablets.	Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.
Our Score	7.3/10	5.1/10
Headline Price	from $199/mo	published $79.99/mo; total not verified
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Users who want to order compounded GLP-1s month-by-month with no subscription commitment	Men who want GLP-1 alongside testosterone or other men's health protocols
Watch out for	Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.	The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
Ranking	#29	#50
Get started	Visit Breeze Meds	Visit Maximus

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required, order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
−Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
−Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.

Maximus

Pros

+Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
−FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding

Our Verdict

Breeze Meds edges out Maximus with a score of 7.3/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Maximus is published $79.99/mo; total not verified.